Total Payments
$2,336
2024 Payments
$373.41
Companies
25
Transactions
154
Medicare Patients
1,787
Medicare Billing
$148,936
Payment Breakdown by Category
Food & Beverage$2,315 (99.1%)
Education$20.88 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,315 | 151 | 99.1% |
| Education | $20.88 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $762.98 | 57 | $0 (2024) |
| PFIZER INC. | $426.61 | 27 | $0 (2024) |
| Novo Nordisk Inc | $386.71 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $183.20 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $111.11 | 7 | $0 (2023) |
| Amgen Inc. | $49.52 | 4 | $0 (2021) |
| Ultragenyx Pharmaceutical Inc. | $47.22 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $40.74 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $40.59 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.25 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $373.41 | 17 | AstraZeneca Pharmaceuticals LP ($137.57) |
| 2023 | $551.12 | 36 | ABBVIE INC. ($275.08) |
| 2022 | $569.09 | 40 | ABBVIE INC. ($258.03) |
| 2021 | $699.33 | 52 | AbbVie Inc. ($150.89) |
| 2020 | $91.10 | 6 | PFIZER INC. ($40.74) |
| 2019 | $51.57 | 3 | KCI USA, Inc ($19.77) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 04/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BREZTRI, FARXIGA | Food and Beverage | In-kind items and services | $98.15 | General |
| Category: Respiratory | ||||||
| 02/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/20/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: RESPIRATORY | ||||||
| 10/05/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 273 | 485 | $64,170 | $27,784 |
| 2022 | 18 | 602 | 972 | $103,755 | $48,176 |
| 2021 | 19 | 561 | 960 | $92,050 | $46,943 |
| 2020 | 12 | 351 | 528 | $56,616 | $26,034 |
Total Patients
1,787
Total Services
2,945
Medicare Billing
$148,936
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 124 | 291 | $40,740 | $17,117 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 38 | 38 | $6,650 | $4,435 | 66.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 51 | 76 | $7,600 | $2,689 | 35.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 43 | $5,160 | $2,158 | 41.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 17 | $2,040 | $826.90 | 40.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 14 | 20 | $1,980 | $557.71 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 297 | $46,732 | $20,284 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 55 | 72 | $10,080 | $4,791 | 47.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 25 | $7,722 | $3,553 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 55 | $5,636 | $3,078 | 54.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 36 | $5,706 | $2,616 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $3,930 | $2,510 | 63.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 48 | $5,620 | $2,508 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 20 | 20 | $3,500 | $2,371 | 67.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 32 | 36 | $3,998 | $1,897 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 29 | 31 | $3,100 | $1,503 | 48.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 18 | 18 | $1,170 | $786.86 | 67.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 18 | $1,902 | $700.15 | 36.8% |
| 20550 | Injection into tendon or ligament | Office | 2022 | 13 | 16 | $1,604 | $538.39 | 33.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 38 | $836.00 | $312.10 | 37.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 22 | 23 | $460.00 | $241.34 | 52.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 15 | 16 | $400.00 | $212.94 | 53.2% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 19 | 19 | $247.00 | $122.21 | 49.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 18 | 26 | $156.00 | $82.12 | 52.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 14 | $70.00 | $41.76 | 59.7% |
About Dr. Jeremiah Nugent, M.D
Dr. Jeremiah Nugent, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1659735421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeremiah Nugent, M.D has received a total of $2,336 in payments from pharmaceutical and medical device companies, with $373.41 received in 2024. These payments were reported across 154 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,315).
As a Medicare-enrolled provider, Nugent has provided services to 1,787 Medicare beneficiaries, totaling 2,945 services with total Medicare billing of $148,936. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wynne, AR
- Active Since 04/07/2016
- Last Updated 10/22/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659735421
Products in Payments
- UBRELVY (Drug) $482.97
- ELIQUIS (Drug) $445.96
- Ozempic (Drug) $243.93
- QULIPTA (Drug) $233.95
- AIRSUPRA (Drug) $112.52
- TRELEGY ELLIPTA (Drug) $83.76
- Rybelsus (Drug) $72.45
- GEMTESA (Drug) $62.66
- EVENITY (Biological) $49.52
- FARXIGA (Drug) $49.04
- Crysvita (Drug) $47.22
- RYBELSUS (Drug) $42.75
- VRAYLAR (Drug) $39.10
- XIFAXAN (Drug) $30.25
- BELSOMRA (Drug) $28.17
- Tresiba (Drug) $27.58
- ANORO ELLIPTA (Drug) $27.35
- BREZTRI (Drug) $21.64
- KERRAMAX CARE (Device) $19.77
- Vascepa (Drug) $18.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wynne
Dr. Mark Bradshaw, M.d, M.D
Family Medicine — Payments: $5,627
Family Medicine $5,627
Dr. Willard Burks, M.d, M.D
Family Medicine — Payments: $5,354
Family Medicine $5,354
Dr. James Cathey, M.d, M.D
Family Medicine — Payments: $4,594
Family Medicine $4,594
Dr. James Beaton, M.d, M.D
Family Medicine — Payments: $3,374
Family Medicine $3,374
Sean Koch, Md, MD
Family Medicine — Payments: $3,138
Family Medicine $3,138
Mrs. Lesli Anderson, Aprn, APRN
Family Medicine — Payments: $390.90
Family Medicine $390.90